Department of Periodontology, Faculty of Dentistry, Gazi University, Ankara, Turkey.
J Periodontol. 2012 Sep;83(9):1172-82. doi: 10.1902/jop.2012.110459. Epub 2012 Jan 5.
Bisphosphonates (BPs) and low-dose doxycycline (LDD) have been shown to inhibit bone resorption and to improve the levels of proinflammatory mediators and destructive enzymes in gingival tissues, respectively. The purpose of this study is to evaluate the effect of mono and combined BP clodronate and LDD therapies in reducing gingival levels of matrix metalloproteinase-9 (MMP-9), interleukin-1β (IL-1β), and alveolar bone loss in rats with diabetes.
Fifty adult Wistar rats were divided into five study groups as follows: 1) group 1 = diabetes control; 2) group 2 = diabetes + periodontitis; 3) group 3 = diabetes + periodontitis + LDD; 4) group 4 = diabetes + periodontitis + clodronate; and 5) group 5 = diabetes + periodontitis + LDD + clodronate. LDD and clodronate were given as a single agent or as combination therapy during the 7 days of the post-experimental periodontitis period. On day 7, the rats were sacrificed, the mobility of the tooth was recorded, and block biopsies were removed. The gingival tissues were analyzed histologically and immunohistochemically for expression of MMP-9 and IL-1β. Alveolar bone loss was evaluated morphometrically under a light microscope. Data analysis was performed statistically by Kruskal-Wallis and post hoc Tukey and Spearman correlation tests.
Alveolar bone loss was significantly greater in groups 2 through 5 than group 1 (P <0.05) but was not significantly different among groups 2 through 5 (P >0.05). Animals with periodontitis (group 2) expressed significantly higher levels of MMP-9 and IL-1β compared with those without periodontitis (group 1) (P <0.05). MMP-9 expression was significantly lower in group 3 than groups 1, 2, and 5 (P <0.05). IL-1β expression was significantly lower in the groups 1, 3, 4, and 5 than 2 (P <0.01) but was not significantly different among groups 1, 3, 4, and 5. Positive correlations were found between alveolar bone loss and density of inflammation (ρ = 0.319, P = 0.021) and between MMP-9 and IL-1β (ρ = 0.418, P = 0.002), respectively.
Our findings suggest that ligature-induced periodontitis in animals with diabetes results in significantly higher levels of MMP-9 and IL-1β expression in gingiva. The use of mono and combined clodronate and LDD administrations may significantly reduce levels of MMP-9 and IL-1β expression. However, drug administration did not affect alveolar bone levels during the study period.
双膦酸盐(BPs)和低剂量强力霉素(LDD)已被证明分别抑制骨吸收并改善牙龈组织中促炎介质和破坏酶的水平。本研究的目的是评估单药和联合 BP 氯膦酸盐和 LDD 治疗在减少糖尿病大鼠牙龈基质金属蛋白酶-9(MMP-9)、白细胞介素-1β(IL-1β)和牙槽骨丢失方面的效果。
将 50 只成年 Wistar 大鼠分为五组:1)组 1 = 糖尿病对照组;2)组 2 = 糖尿病+牙周炎组;3)组 3 = 糖尿病+牙周炎+LDD 组;4)组 4 = 糖尿病+牙周炎+氯膦酸盐组;5)组 5 = 糖尿病+牙周炎+LDD+氯膦酸盐组。在牙周炎后实验期的 7 天内,LDD 和氯膦酸盐分别作为单一药物或联合治疗给予。第 7 天,处死大鼠,记录牙齿的活动性,并取出块状活检。用组织学和免疫组织化学方法分析牙龈组织中 MMP-9 和 IL-1β 的表达。在光镜下对牙槽骨丢失进行形态计量学评估。通过 Kruskal-Wallis 和事后 Tukey 和 Spearman 相关检验进行统计数据分析。
与组 1 相比,组 2 至 5 的牙槽骨丢失明显更大(P<0.05),但组 2 至 5 之间无显著差异(P>0.05)。与无牙周炎的组 1 相比,患有牙周炎的组 2 (P<0.05)表达的 MMP-9 和 IL-1β 水平明显更高。与组 1、2 和 5 相比,组 3 的 MMP-9 表达明显更低(P<0.05)。与组 2 相比,组 1、3、4 和 5 的 IL-1β 表达明显更低(P<0.01),但组 1、3、4 和 5 之间无显著差异。分别发现牙槽骨丢失与炎症密度之间存在正相关(ρ=0.319,P=0.021)和 MMP-9 与 IL-1β 之间存在正相关(ρ=0.418,P=0.002)。
我们的研究结果表明,糖尿病动物结扎诱导的牙周炎导致牙龈中 MMP-9 和 IL-1β 的表达水平显著升高。使用单药和联合氯膦酸盐和 LDD 给药可能会显著降低 MMP-9 和 IL-1β 的表达水平。然而,在研究期间,药物给药并未影响牙槽骨水平。